Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Current Assets (2016 - 2025)

Historic Current Assets for Bio-Techne (TECH) over the last 16 years, with Q4 2025 value amounting to $637.4 million.

  • Bio-Techne's Current Assets rose 43.99% to $637.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $637.4 million, marking a year-over-year increase of 43.99%. This contributed to the annual value of $608.3 million for FY2025, which is 147.7% down from last year.
  • Bio-Techne's Current Assets amounted to $637.4 million in Q4 2025, which was up 43.99% from $609.5 million recorded in Q3 2025.
  • Bio-Techne's Current Assets' 5-year high stood at $648.6 million during Q3 2024, with a 5-year trough of $510.6 million in Q2 2021.
  • Moreover, its 5-year median value for Current Assets was $599.3 million (2022), whereas its average is $594.8 million.
  • Per our database at Business Quant, Bio-Techne's Current Assets soared by 1859.56% in 2022 and then plummeted by 602.25% in 2025.
  • Over the past 5 years, Bio-Techne's Current Assets (Quarter) stood at $590.2 million in 2021, then fell by 4.24% to $565.2 million in 2022, then grew by 4.5% to $590.6 million in 2023, then increased by 7.45% to $634.6 million in 2024, then grew by 0.44% to $637.4 million in 2025.
  • Its last three reported values are $637.4 million in Q4 2025, $609.5 million for Q3 2025, and $608.3 million during Q2 2025.